News und Analysen
ASH 2017: CAR-T Wallops Blood Cancer
The American Society of Hematology (ASH) annual meeting this past weekend was chock-full of excitement, including an unexpected snowstorm in Atlanta and a slew of game-changing non-Hodgkin....
What Happened in the Stock Market Today
Stocks moved higher on Monday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) closing at record highs.Data source: Yahoo! Finance.Telecom and tech....
3 Stocks to Hold for the Next 20 Years
As Warren Buffett has said, "It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price." For long-term investors, this rings especially true, as a great....
Here's Why Syros Pharmaceuticals Got Crushed Today
Shares of Syros Pharmaceuticals (NASDAQ: SYRS) dropped by as much as 49.1% Monday after the company provided a clinical update on its lead drug candidate. Investors probably couldn't tell by the....
Why Seattle Genetics, Inc. Fell Today
Seattle Genetics (NASDAQ: SGEN) is down 5.9% as of this writing, having been down as much as 10.5% Friday following a weekend of presentations at the American Society of Hematology (ASH)....
Why Seattle Genetics, Inc. Fell Today
Seattle Genetics (NASDAQ: SGEN) is down 5.9% as of this writing, having been down as much as 10.5% Friday following a weekend of presentations at the American Society of Hematology (ASH)....
Here's Why Spark Therapeutics, Inc. Is Getting Hammered Today
Shares of Spark Therapeutics, Inc. (NASDAQ: ONCE), a biotech developing gene therapies, fell hard this morning after the company reported hemophilia trial data that bodes well for rival BioMarin....
BOIRON : Formulaire de déclaration mensuelle des droits de vote au 30 novembre 2017
Le 11 décembre 2017
Publication
du nombre d'actions composant le capital et du nombre total de droits de vote
(articles L. 233-8 II du code de commerce et 223-16 du règlement général de....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Better Buy: Illumina, Inc. vs. Pacific Biosciences
Rapid advances in the ability to quickly and cheaply sequence DNA and RNA are fueling research in cancer, immunology, complex diseases, forensics, agriculture, and many other areas, while clinical....
Here's What Pushed Arena Pharmaceuticals, Inc. Up 10.6% in November
Shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a biotech rising like a phoenix from the ashes of Belviq's commercial flop, rose 10.6% in November, according to data from S&P Global....
bluebird bio Stock Soars on Unprecedented Blood Cancer Study Results
Shares of the clinical-stage biotech bluebird bio (NASDAQ: BLUE) rose by as much as 23.9% in pre-market trading today. The catalyst? The company reported that its CAR-T candidate, bb2121, produced....
The 3 Marijuana Stocks With the Most Cash on Their Balance Sheets
There aren't too many industries that can hold a candle to the returns of cryptocurrencies these days, but the marijuana industry isn't going down without a fight. Marijuana stocks certainly have....
Why 2018 Could Be the Best Year Yet for Cara Therapeutics
Most investors would be excited if one of the stocks they owned achieved a 45% gain in less than a year. But for Cara Therapeutics (NASDAQ: CARA) shareholders, that level of performance is....
2018 Is a Critical Year for These 3 Small Commercial-Stage Biotech Stocks
Making the leap from clinical-stage to the commercial-stage drug isn't easy. It requires an entirely different set of experience to navigate the world of private and public payers and a big....
You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed
For years, chemotherapy was the best treatment that the world of medicine had to offer in fighting cancer. That's no longer true. A powerful new class of cancer drugs called immunotherapies has....
You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed
For years, chemotherapy was the best treatment that the world of medicine had to offer in fighting cancer. That's no longer true. A powerful new class of cancer drugs called immunotherapies has....
You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed
For years, chemotherapy was the best treatment that the world of medicine had to offer in fighting cancer. That's no longer true. A powerful new class of cancer drugs called immunotherapies has....
Is Gilead Sciences, Inc. a Buy?
With only a few weeks remaining in 2017, Gilead Sciences (NASDAQ: GILD) stock price appears to be on course to finish roughly at the same level that it began the year. After getting off to a rocky....
Is Gilead Sciences, Inc. a Buy?
With only a few weeks remaining in 2017, Gilead Sciences (NASDAQ: GILD) stock price appears to be on course to finish roughly at the same level that it began the year. After getting off to a rocky....
Is Gilead Sciences, Inc. a Buy?
With only a few weeks remaining in 2017, Gilead Sciences (NASDAQ: GILD) stock price appears to be on course to finish roughly at the same level that it began the year. After getting off to a rocky....
Why Opko Health Stock Stumbled in November
Shares of Opko Health (NASDAQ: OPK) had another poor showing in November, with its stock shedding a whopping 19.5% of its value last month, according to data from S&P Global Market....
3 Growth Stocks I'd Buy Right Now
What's a six-letter word that's guaranteed to make investors happy? Growth. While growth comes in several flavors, they're all interrelated. Growth in revenue helps make earnings growth possible,....
3 Growth Stocks I'd Buy Right Now
What's a six-letter word that's guaranteed to make investors happy? Growth. While growth comes in several flavors, they're all interrelated. Growth in revenue helps make earnings growth possible,....